High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor

International Journal of Cardiology

Volumn 141, Issue 3, 2010, Pages 320-322

  Fukutomi, Tatsuya ^a   Takeda, Yutaka ^b   Suzuki, Shogo ^b   Ito, Tatsuya ^b   Joh, Takashi ^b   Itoh, Makoto ^c  

^a Asuke Hospital 20   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c Nagoya University of Economics   (Japan)

Author keywords

Apolipoprotein A I; High density lipoprotein cholesterol; Pitavastatin

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PITAVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGED; APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; QUINOLINES;

EID: 77952744253     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.11.130     Document Type: Article

References (8)

1. Gordon D.J., and Rifkind B.M. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 321 19 (1989) 1311-1316
2. Singh I.M., Shishehbor M.H., and Ansell B.J. High-density lipoprotein as a therapeutic target: a systematic review. JAMA 298 7 (2007) 786-798
3. Olsson A.G., Istad H., Luurila O., et al. Rosuvastatin Investigators Group., Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. Am Heart J 144 6 (2002) 1044-1051
4. Hayashi T., Yokote K., Saito Y., and Iguchi A. Pitavastatin: efficacy and safety in intensive lipid lowering. Expert Opin Pharmacother 8 14 (2007) 2315-2327
5. Crouse III J.R., Frohlich J., Ose L., et al. Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. Am J Cardiol. 83 10 (1999) 1476-1477
6. Kastelein J.J., Isaacsohn J.L., Ose L., et al. Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels. Am J Cardiol 86 2 (2000) 221-223
7. Maejima T., Yamazaki H., Aoki T., et al. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell. Biochem Biophys Res Commun 324 2 (2004) 835-839
8. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150